APPN APPIAN CORP Insider Trading

CEO Matthew W Calkins sold 50,000 shares at $24.72 avg ($1.2M) via pre-arranged 10b5-1 plan; holds 1.72M post-sale.

Matthew W Calkins, CEO and President, executed 2 separate sales totaling 50,000 shares for $1,236,243.10 on 2026-07-07 under a 10b5-1 trading plan adopted on 2026-03-05. The scheduled nature of this transaction precludes any interpretation of timing judgment or market sentiment. His post-transaction holdings of 1,719,144 shares represent a -2.8% reduction from pre-transaction holdings of 1,769,144 shares. The stock currently trades at $24.27, down 47.3% from the 52-week high of $46.06, and the company reported a net loss of $1,525,000 in the latest quarter despite 17.8% annual revenue growth. The prior sale at APPN on 2026-06-08 returned 0.6% over 30 days, establishing a measured pattern of activity at this ticker.

CEO Matthew W Calkins sold 50,000 shares of APPN at $24.13 on 2026-06-08 via pre-arranged 10b5-1 plan; stock -47.9% from 52-week high.

Matthew W Calkins, CEO and President, sold 50,000 shares at $24.13 for $1,206,500.00 on 2026-06-08 under a 10b5-1 trading plan adopted on 2026-03-05, meaning this sale was scheduled and not discretionary. Post-transaction, Calkins retains 1,769,144 shares. The stock currently trades at $24.01, down -47.9% from the 52-week high of $46.06, though it has risen +28.3% over the prior 30 days. Appian reported latest-quarter revenue of $202,180,000.00 and net income of -$1,525,000.00, with annual revenue growth of +17.8%, indicating growth in top line despite current-period losses. The pre-arranged nature of this sale precludes any inference about Calkins's current conviction or market timing; investors should monitor whether scheduled 10b5-1 sales continue as planned and track whether the company's profitability trajectory improves given the recent revenue strength.

Chief Revenue Officer Mark Dorsey makes first open-market share purchase, acquiring 5,227 shares as stock trades well below 52-week high.

Mark Dorsey, Appian's Chief Revenue Officer, made his first open-market share purchase—a significant shift from his prior pattern of receiving stock through compensation alone. He acquired over 5,200 shares using personal capital while the stock trades substantially below its 52-week high and has declined over the prior quarter, suggesting he is willing to increase his stake during a period of weakness. The company remains profitable with solid annual revenue growth, though the most recent quarter showed a loss, providing a mixed financial backdrop for the purchase. This move is noteworthy precisely because it is Dorsey's first time buying on the open market in the three-year filing window—a deliberate step that distinguishes him from an executive who passively holds stock received as pay.

10% owner Abdiel Capital liquidates 1,057,839 shares (19.9% of holdings) for $31,366,506.75 over 3 days

Abdiel Capital Advisors, LP executed 14 separate sales totaling 1,057,839 shares for $31,366,506.75 between 2025-08-06 and 2025-08-08, reducing its stake from 5,304,123 shares to 4,246,284 shares. The blended average sale price of $29.65 sits 1.9% above the current price of $29.09 and notably 30.0% below the 52-week high of $41.56, indicating the insider sold into a stock that has declined significantly from its recent peak. The rapid multi-day execution and substantial 19.9% portfolio reduction by a major shareholder in a company with negative net income ($-312,000.00 in the latest quarter) signals a material reassessment of position sizing. The absence of measurable prior outcomes at APPN and the narrowly executed window (3 days) limit comparison to historical patterns but the scale—1.06M shares—and timing relative to recent 52-week deterioration (-30.0% from high) warrant close monitoring of subsequent trading and fundamentals.

10% owner Abdiel Capital sells 636,594 shares ($19.2M) across 3 days at $29.71–$31.01 while stock -30.3% from 52-week high

Abdiel Capital Advisors, LP executed 12 separate sales totaling 636,594 shares for $19,177,499.56 across July 25–29, 2025, at prices ranging from $29.71 to $31.01 (blended average $30.13). This reduces the 10% owner's stake from 5,940,717 shares to 5,304,123 shares (-10.7% reduction). The sales occurred against a backdrop of significant price weakness: the stock is trading 30.3% below its 52-week high of $41.56 and has declined 6.7% over 90 days. Appian remains unprofitable (full-year net income was negative), though the company posted +13.1% annual revenue growth and $166.4M in latest-quarter revenue. The timing of these sales during a sustained downtrend warrants investor attention, particularly given that prior trades at this ticker (5 recent sells on July 23–24) have not yet proven well-timed at the 90-day mark.

10% owner Abdiel Capital Advisors sold 576,411 shares for $17.1M across three days at blended avg $29.70

Abdiel Capital Advisors, LP executed 10 separate sales totaling 576,411 shares for $17,118,717.80 between July 22–24, 2025, reducing its stake from 6.52M to 5.94M shares (-8.8%). The multi-transaction structure across three trading days at prices ranging from $28.77 to $30.14, near a 52-week high of $41.56, suggests a programmatic reduction. The company is currently unprofitable (full-year net income was negative) despite 13.1% annual revenue growth, and the stock is down 29.0% from its 52-week peak. The insider's cross-ticker track record shows 20 prior sells, though outcomes at this specific ticker remain unmeasurable given the recent July 2025 transaction date. Investors should monitor whether this represents a portfolio rebalancing by a large shareholder or a signal of confidence changes regarding Appian's near-term path.

10% Owner Abdiel Capital sold 290,685 shares over 3 days for $8.4M at blended avg $28.80

Abdiel Capital Advisors, a 10% owner, executed 8 separate sales totaling 290,685 shares for $8,370,316.78 across July 17–21, 2025, reducing holdings from 6.81M to 6.52M shares (-4.3%). The blended average price of $28.80 sits 30.3% below the 52-week high of $41.56, and the stock has advanced 2.7% over 30 days and 8.3% over 90 days. The company reported revenue of $166,426,000.00 in the latest quarter with net income of -$1,177,000.00, showing unprofitability on a full-year basis despite 13.1% annual revenue growth. Prior trades at this ticker (5 sells since July 11) have outcomes not yet measurable, and no pattern of well-timed sales is evident from the insider's prior transaction history. The sustained selling activity—multiple tranches over four trading days—during a period of stock recovery from a depressed level warrants investor attention to assess whether the liquidation reflects underlying operational or confidence concerns.

10% owner Abdiel Capital sells 131,987 shares across 4 trades (7/14–7/16) for $3.8M; stock down -5.0% (30d), -30.4% from highs.

Abdiel Capital Advisors, LP executed 4 separate sales totaling 131,987 (132.0K shares) for $3,811,698.44 ($3.8M) at a blended average price of $28.88, reducing its position by -1.9% to 6,807,813 (6.81M shares) post-transaction. The timing is notable: sales occurred on 2025-07-14 (at $30.12) and 2025-07-16 (at $28.81), coinciding with a 30-day stock decline of -5.0% and a pullback of -30.4% from the 52-week high of $41.56. The company reported revenue of $166,426,000.00 ($166.4M) in the latest quarter but was unprofitable (net income $-1,177,000.00) and unprofitable over the full fiscal year, suggesting operational headwinds despite annual revenue growth of +13.1%. The insider's cross-ticker track record shows 20 prior sells with an average 30-day return of -8.8%, while same-ticker outcomes at APPN remain unmeasurable due to recency. The confluence of sales during price weakness, company unprofitability, and the insider's historical pattern of selling into downturns warrants attention to whether this signals concern over near-term fundamentals or valuation.

10% owner Abdiel Capital sold 288,590 shares ($9.0M) at $31.04 avg over Jul 9-11; stock down -31.0% from 52-week high, unprofitable

Abdiel Capital, a 10% shareholder, executed 8 separate sales totaling 288,590 shares for $8,958,219.27 over three trading days (July 9–11), reducing holdings by 4.0% to 6,939,800 shares at a blended average price of $31.04. The stock is currently trading at $28.69, down -31.0% from its 52-week high of $41.56, and the company reported a negative net income of $-1,177,000 over its latest full fiscal year despite revenue of $166,426,000 with annual growth of 13.1%. The timing of this sale sequence—conducted as the stock trades well below its peak—and the company's underlying unprofitability merit investor attention to whether this represents a significant reshuffling by a major institutional holder or reflects broader concerns about valuation and profitability.

10% owner Abdiel Capital Advisors sold 301.4K shares for $9.3M across 7 sales July 3–8 at prices from $30.45–$31.27; retains 7.23M shares post-sale.

Abdiel Capital Advisors, a 10% shareholder, executed 7 separate sales totaling 301,379 shares for $9,343,318.24 over a five-day window (July 3–8, 2025), reducing its stake by 4.0% from 7.53M to 7.23M shares. The sales occurred at a blended average price of $31.00 per share, compared to the current market price of $31.30 (a subsequent modest uptick of +0.97%). This represents the latest in a cluster of five prior sales at APPN within the preceding two weeks (June 11, June 30, July 1 twice, and July 2), signaling sustained high-volume liquidation from a major holder. While the company reported revenue growth of 13.1% year-over-year and a current market cap of $2.3B, it remains unprofitable, with a net loss of $1.2M in the most recent quarter and negative full-year net income. The timing of these coordinated sales against the backdrop of near-term weakness (stock down 2.7% over 30 days and 24.7% from its 52-week high of $41.56) and persistent unprofitability warrants investor attention to the holder's apparent reduction of its strategic position.